FDA Drug Application (062833) for BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE by NASKA

Back to FDA Applications sponsored by NASKA

Application Number062833
Product Number001
FormOINTMENT;TOPICAL
Dosage400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
Active IngredientBACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE



Back to FDA Applications sponsored by NASKA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.